Select from the search options to widen or narrow the search results.
Stage 11 Colon Cancer (E5202)
The Purpose of this study is to compare the effects of a combination of chemotherapy drugs, when given with and without a new drug, bevacizumab, on patients with stage II colon cancer at high-risk for recurrence.
To Participate in the study you must:
For more information in Sheboygan, please contact Deb Gray 920-457-6800 ext 2660 or debbie.gray@aurora.org
Principal Investigator, Santhosh Kumar, MD
For more information in Oskosh, please contact Barbara Esselman at 920-456-7880 or barbara.esselman@auora.org
Principal Investigator, Zahid Dar, MD
For more information in Elkhorn, please contact Carol Thomas at 414-649-5605 or carol.thomas@aurora.org
Principle Investigator, Sailaja Kamaraju, MD
For more information in Green Bay, please contact Kate Newbanks 920-288-4115 kate.newbanks@aurora.org or Lori McElrone 920-288-4174 lori.mcelrone@aurora.org
Principal Investigator: Dhimant Patel, M.D.